Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why is hypertension reaching the cardiologist? Observations from a community practice.

The American journal of medicine·2026
Same author

Rethinking cardiovascular disease screening in the era of AI-enhanced coronary CT angiography.

Clinical imaging·2026
Same author

Integrating Anatomy and Ischemia in Chest Pain Evaluation.

The American journal of cardiology·2026
Same author

Coronary calcium without context: when a risk tool becomes a screening liability.

The American journal of medicine·2026
Same author

Induction of Hypopituitarism Following Ipilimumab/Nivolumab Therapy Followed by Radiation in the Treatment of Metastatic Scalp Melanoma.

HCA healthcare journal of medicine·2023
Same author

<i>Bartonella henselea</i> Prosthetic Valve Endocarditis Mimicking Vasculitis: A Case Report With Literature Review.

HCA healthcare journal of medicine·2023

Related Experiment Video

Updated: Jul 20, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.4K

Convalescent Plasma in COVID-19.

Ranjit S Banwait1, Joshua K Salabei1, Troy J Fishman1

  • 1University of Central Florida/ HCA Healthcare North Florida Regional Medical Center.

HCA Healthcare Journal of Medicine
|July 10, 2023
PubMed
Summary

Convalescent plasma (CP) is a potential treatment for COVID-19, offering an option when no definitive therapies exist. This review examines CP

Keywords:
COVID-19COVID-19 serotherapyCoronavirusSARS-CoV-2emerging communicable diseasesintravenous immunoglobulinspassive immunizationplasma

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.0K

Related Experiment Videos

Last Updated: Jul 20, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.4K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.0K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Virology

Background:

  • The COVID-19 pandemic caused by SARS-CoV-2 has created a global health crisis.
  • Effective treatments are urgently needed to combat the spread of SARS-CoV-2.
  • No definitive antiviral treatment currently exists for COVID-19.

Purpose of the Study:

  • To review the historical use of convalescent plasma (CP) in treating infections.
  • To explore the mechanism of action of CP.
  • To summarize current experiences with CP for COVID-19 treatment.

Main Methods:

  • Literature review of historical CP usage.
  • Analysis of CP's therapeutic mechanisms.
  • Compilation of data on CP application in COVID-19.

Main Results:

  • Convalescent plasma has a history of use in various infectious diseases.
  • CP contains antibodies that may neutralize pathogens.
  • Early experiences with CP in COVID-19 are being documented.

Conclusions:

  • Convalescent plasma is a viable therapeutic option for COVID-19.
  • Further research is needed to fully establish CP efficacy and safety.
  • CP represents a promising approach in the absence of specific treatments.